Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir and Ribavirin for HCV Genotype 1 in HIV-Coinfected Patients on Stribild
NCT02220868Phase 4Completed
- Sponsor
- Saint Michael's Medical Center
- Start
- Jul 2014
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir, ribavirin in hepatitis C virus infection, sponsored by Saint Michael's Medical Center. Started Jul 2014; status: completed.
02
Drugs
sofosbuvirribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02220868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02220868.